ANGPT1 and neoplasm: This lack of clinical efficacy raises a question: Could concurrent Ang1 inhibition actually be compromising the anti-metastatic efficacy of Ang2-specific inhibition by destabilizing systemic blood vessels to promote distant metastatic spread, despite the expected additive benefit in local tumor growth suppression (Cascone & Heymach, 2012)?